TUATARA CAPITAL, L.P.
TUATARA CAPITAL, L.P. is a Series A, Series B, Series C+, buyout and venture fund in the US, Canada, Europe and South America investing in Enterprise, Healthcare, cannabis and consumer-products.
- Stages
- Series A, Series B, Series C+, buyout, venture
- Sectors
- Enterprise, Healthcare, cannabis, consumer-products
- Invests in
- US-wide, Canada, Europe, South America
- Actively investing
- Yes
- Founded
- 2014
- Assets under management
- $400M
Check size not disclosed
Thesis
Tuatara Capital, L.P. is a private equity firm founded in 2014 and based in New York, with a dedicated focus on the legal cannabis industry. The firm invests in growth-stage companies across the entire cannabis value chain, including research, testing, cultivation, processing, consumer products, and technology. Their investment thesis is driven by the long-term growth trends in distinct cannabis markets such as social consumption, cannabinoid pharmaceuticals, and health and wellness. Tuatara Capital employs both minority and majority investment strategies, utilizing growth equity and buyout approaches. Geographically, their primary focus is North America (US and Canada), with an interest in expanding into Europe and South America as legalization progresses. Despite U.S. federal prohibition, they are open to "plant-touching" investments. As of June 2024, the firm managed approximately $400 million in committed capital. They have a history of raising multiple funds, with their first fund closing in 2016 at $93 million. The firm's typical check size is implied to be substantial, likely in the millions, given their focus on growth-stage companies and involvement in acquisitions and larger funding rounds.
Common questions
Does TUATARA CAPITAL, L.P. invest at the Series A stage?
Yes. TUATARA CAPITAL, L.P. lists Series A, Series B, Series C+, buyout and venture among the stages it invests in.
Where does TUATARA CAPITAL, L.P. invest?
TUATARA CAPITAL, L.P. invests in the US, Canada, Europe and South America.